Metraipolis › archive › dc_a1e87c9fcdba
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer — Europe PMC PMID:41315064
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41315064
- DOI
- 10.1007/s00280-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T04:07:06.567Z
- SHA-256 of the archived text
5b9603363381febd586600559a075377e1b711d56d230588dc0630ece07b867d- Stable URL of this page
https://metraipolis.com/documento/dc_a1e87c9fcdba
How to cite
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer — Europe PMC PMID:41315064 — Europe PMC (en), https://europepmc.org/article/MED/41315064 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a1e87c9fcdba (Metraipolis archive dc_a1e87c9fcdba, sha256 5b9603363381febd586600559a075377e1b711d56d230588dc0630ece07b867d)
BibTeX
@misc{dca1e87c9fcdba,
title = {Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer — Europe PMC PMID:41315064},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41315064},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a1e87c9fcdba; sha256 5b9603363381febd586600559a075377e1b711d56d230588dc0630ece07b867d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41315064. Agents can read the archived copy with the MCP tool read_document.